BioSpace News Archive

Biotech Bay

Gilead Outlines Efforts to Expand Global Supply of Remdesivir for COVID-19

On May 5, the company issued a statement describing their efforts.

May 6, 2020
·
2 min read
·
Mark Terry
Deals

Number of Shares and Voting Rights of Innate Pharma as at May 1, 2020

Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities charter, Innate Pharma SA releases its total number of shares outstanding as well as its voting rights as at May 1, 2020

May 6, 2020
·
4 min read
Drug Development

Targovax Announces That Abstract on Interim Phase I Clinical Data From the Phase I/II Peritoneal Trial is Accepted at ASCO

Targovax ASA announces that interim phase I clinical data from the phase I/II trial evaluating systemic durvalumab + intraperitoneal ONCOS-102 in patients with peritoneal disease originating from ovarian or colorectal cancer, will be presented at the ASCO20 Virtual Scientific conference, 29-31 May 2020.

May 6, 2020
·
1 min read
Policy

Relief Therapeutics Holding (RLF:SIX) Drug Aviptadil Enters FDA Trial at NYU Langone Health, New York, to Treat COVID-19-Induced Acute Respiratory Distress

Aviptadil targets the cytokine storm that causes fatal Respiratory Distress in COVID-19

May 6, 2020
·
4 min read
Business

OssDsign Appoints VP of Sales for OssDsign USA, Inc to Drive Continued Growth in the Company’s Largest Market

OssDsign announces the appointment of Eric Patermo as VP of Sales for OssDsign USA, Inc, a wholly owned subsidiary of OssDsign AB.

May 6, 2020
·
3 min read
Deals

C-RAD AB - Interim Report January - March 2020

The first quarter of 2020 generated solid results, despite being a period where unexpected events played a role.

May 6, 2020
·
4 min read
Drug Development

InteRNA Technologies Receives Regulatory Approval for Initiation of Phase I Clinical Trial of INT-1B3 in Patients with Advanced Solid Tumors

First-in-human trial will test the safety, pharmacokinetics and preliminary efficacy of microRNA therapeutic candidate INT-1B3

May 6, 2020
·
4 min read
Business

OneOncology Names Jeff Patton, MD as CEO

OneOncology, the national partnership of independent community oncologists, announced that Jeff Patton, MD has been named Chief Executive Officer.

May 6, 2020
·
3 min read
Policy

Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate COVID-19 Clinical Trial

Company to test LAU-7b’s dual pro-resolving inflammation and antiviral properties against COVID-19

May 6, 2020
·
3 min read
BioMidwest

Magellan Health to Participate at BofA Securities Health Care Conference

Magellan Health, Inc. announced that Kenneth Fasola, chief executive officer of Magellan Health, and Jonathan Rubin, chief financial officer of Magellan Health, will participate in a fireside chat at the 2020 BofA Securities Health Care Conference on May 13, 2020, through a virtual webcast.

May 6, 2020
·
1 min read